While RLE is an investment, it’s one that pays off over time. The recurring expense of glasses, contact lenses, and eye exams ...

The World Health Organization (WHO) has partnered with the Universal Postal Union (UPU) to expand access to eye care using ...

ARVO presentation highlights 12-month results from Phase 1/2 study that support potential of OPGx-LCA5 gene therapy to ...

A once-daily preservative-free eye drop can significantly improve near and distance vision in presbyopia and is well-tolerated.

LENZ has announced an exclusive licensing and commercialisation agreement with Lotus Pharmaceutical of Taiwan.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Visakhapatnam: A 15-year follow-up of 5,395 participants from the erstwhile combined Andhra Pradesh (encompassing both ...

SAN DIEGO and TAIPEI, Taiwan, May 09, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LENZ) and Lotus Pharmaceutical Co., Ltd. (“Lotus”, TWSW Stock Code: 1795) today announced an exclusive ...

Research and Development (R&D) Expenses: R&D expenses decreased to $5.8 million for the three months ended March 31, 2025, ...

Pilocarpine hydrochloride 1.25% significantly improves near visual acuity in patients with presbyopia, but it is also associated with increased risks of headache, facial pain, and blurred vision, ...

Most patients were not bothered by most visual disturbances. LOS ANGELES — Patients implanted with a presbyopia-correcting IOL reported high satisfaction after surgery and preserved visual ...

In presbyopia, Krueger said ESWT has shown promise in improving lens elasticity in porcine models. In cataracts, it helped improve lens clarity and lens volume. Krueger said he could see ...